Skip to content
Stock Focus Report

Stock Focus Report

Primary Menu
  • Home
  • Business
  • Economy
  • Domestic
  • Money
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2024
  • November
  • 6
  • Tesla investors lose bid for new US trial over Musk’s 2018 tweets
  • Business

Tesla investors lose bid for new US trial over Musk’s 2018 tweets

Stock Focus Report November 6, 2024
2024-11-06T192622Z_2_LYNXMPEKA50WO_RTROPTP_4_AI-BRITAIN-SUMMIT

By Nate Raymond

(Reuters) – A U.S. appeals court on Wednesday upheld a jury’s verdict clearing Tesla CEO Elon Musk and his company of liability over allegations they misled investors when the billionaire posted on social media in 2018 that he had “funding secured” to take the electric car company private.

The San Francisco-based 9th U.S. Circuit Court of Appeals rejected arguments by lawyers for Tesla investors that the instructions jurors received on the law from the judge presiding over the case before they delivered their verdict in February 2023 were flawed, warranting a new trial.

Lawyers for Tesla shareholders argued the jury instructions were confusing and impermissibly heightened their burden of proof by requiring them to establish Musk knowingly made false statements when he wrote his posts on Twitter, the platform now known as X following Musk’s $44 billion acquisition of it in 2022.

They said U.S. District Judge Edward Chen gave that flawed instruction even though before the trial he had held Musk’s tweets were inaccurate and that he acted recklessly, making it unnecessary for the shareholders in the class action lawsuit to prove Musk acted knowingly.

But Wednesday’s three-judge panel disagreed, saying that while Musk had been found to have, at a minimum, tweeted recklessly, the question of whether he acted knowingly was still relevant if jurors needed to decide how to apportion damages between the defendants in the case, including Tesla directors.

Ellyde Thompson, a lawyer for Musk and Tesla, welcomed the decision. A lawyer for the plaintiffs did not respond to requests for comment.

The case was filed in 2018 and concerned posts on Twitter that had also led to a $40 million securities fraud settlement later that year between Musk, Tesla and the U.S. Securities and Exchange Commission.

The SEC probe and investors’ lawsuit stemmed from a tweet Musk posted on Aug. 7, 2018, saying he was considering taking Tesla private at $420 per share, a premium of about 23% to the prior day’s close, and had “funding secured.”

Later that day, he tweeted: “Investor support is confirmed.”

Tesla’s stock price soared after the tweets and then fell again after Aug. 17, 2018, as it became clear the buyout would not happen. The shareholders’ lawyers accused Tesla and Musk of misleading investors, costing them billions of dollars.

(Reporting by Nate Raymond in Boston; Editing by Diane Craft)

Continue Reading

Previous: Blackstone Real Estate to take Retail Opportunity private in $4 billion deal
Next: Factbox-Trump’s US election win may bring NATO members’ defense spending back into focus

Related Stories

2025-05-15T131423Z_4_LYNXMPEL4E0HS_RTROPTP_4_UNITEDHEALTH-DOJ.JPG
  • Business

UnitedHealth shares slide as criminal probe report adds to investor fears

Stock Focus Report May 15, 2025
2025-05-15T182409Z_1_LYNXMPEL4E118_RTROPTP_4_CVS-HEALTH-RESULTS
  • Business

CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports

Stock Focus Report May 15, 2025
2025-05-14T191536Z_1_LYNXMPEL4D0YN_RTROPTP_4_UBER-TRENDYOL
  • Business

Uber and iFood announce strategic partnership in Brazil

Stock Focus Report May 14, 2025

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • UnitedHealth Suffers Sell-Off After Probe Surfaces
  • UnitedHealth shares slide as criminal probe report adds to investor fears
  • CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports
  • Hidden Gem’s – Tomorrow’s Market Secrets – Delivered Today
  • Amgen owes $406 million for monopolizing cholesterol drug market, US jury says

Categories

  • Business
  • Domestic
  • Economy
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized

You may have missed

  • Newsletters

UnitedHealth Suffers Sell-Off After Probe Surfaces

Stock Focus Report May 15, 2025
2025-05-15T131423Z_4_LYNXMPEL4E0HS_RTROPTP_4_UNITEDHEALTH-DOJ.JPG
  • Business

UnitedHealth shares slide as criminal probe report adds to investor fears

Stock Focus Report May 15, 2025
2025-05-15T182409Z_1_LYNXMPEL4E118_RTROPTP_4_CVS-HEALTH-RESULTS
  • Business

CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports

Stock Focus Report May 15, 2025
  • Uncategorized

Hidden Gem’s – Tomorrow’s Market Secrets – Delivered Today

Stock Focus Report May 15, 2025
  • Home
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Disclaimer
  • Contact Us
Copyright © All rights reserved. | MoreNews by AF themes.